These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2670485)

  • 1. Limitations in the measurement of c-myc oncoprotein and other nuclear antigens by flow cytometry.
    Lincoln ST; Bauer KD
    Cytometry; 1989 Jul; 10(4):456-62. PubMed ID: 2670485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodologies for the preservation of proliferation associated antigens PCNA, p120, and p105 in tumor cell lines for use in flow cytometry.
    Mikulka WR; Bolton WE
    Cytometry; 1994 Nov; 17(3):246-57. PubMed ID: 7851160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluctuations and ultrastructural localization of oncoproteins and cell cycle regulatory proteins during growth and apoptosis of synchronized AGF cells.
    Gazitt Y; Erdos GW
    Cancer Res; 1994 Feb; 54(4):950-6. PubMed ID: 7906198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of the c-myc oncoprotein in human glioblastoma cells and tumor tissue.
    Engelhard HH; Butler AB; Bauer KD
    J Neurosurg; 1989 Aug; 71(2):224-32. PubMed ID: 2545843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
    De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
    Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S; Chatten J; Hanada M; Reed JC
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous analysis of c-myc protein expression and cell cycle with monoclonal antibody and flow cytometry].
    Mizuta S; Takamoto S; Naoe T
    Nihon Rinsho; 1992 Oct; 50(10):2465-70. PubMed ID: 1447818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization and fluctuation in the level of the proliferating cell nuclear antigen and myc oncoproteins in synchronized neuroblastoma cells.
    Gazitt Y; Erdos GW; Cohen RJ
    Cancer Res; 1993 Apr; 53(8):1899-905. PubMed ID: 8096797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the c-myc oncoprotein in human metaplastic epithelial cells of fibrocystic disease.
    Papamichalis G; Francia K; Karachaliou FE; Anastasiades OT; Spandidos DA
    Anticancer Res; 1988; 8(6):1217-22. PubMed ID: 3064712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins.
    Moore JP; Hancock DC; Littlewood TD; Evan GI
    Oncogene Res; 1987; 2(1):65-80. PubMed ID: 3333275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of tissue preparation techniques on p53 expression in bronchial and bladder carcinomas, assessed by immunofluorescence staining and flow cytometry.
    Mørkve O; Høstmark J
    Cytometry; 1991; 12(7):622-7. PubMed ID: 1782831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of nuclear c-MYC oncoprotein expression in human hematopoiesis: suitability of a rapid and reliable semiquantitative evaluation system.
    Greil R; Fasching B; Weger A; Loidl P
    Lab Invest; 1992 Feb; 66(2):251-60. PubMed ID: 1735958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry.
    Bauer KD; Clevenger CV; Endow RK; Murad T; Epstein AL; Scarpelli DG
    Cancer Res; 1986 May; 46(5):2428-34. PubMed ID: 3516382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
    Chen HW; Huang HC
    Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells.
    Craig RW; Buchan HL; Civin CI; Kastan MB
    Cell Growth Differ; 1993 May; 4(5):349-57. PubMed ID: 8518229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.